FDA
Sodium Iodide I 123
The FDA lists this product in 8 strengths and forms.
Indications
AND USE Administration of Sodium Iodide I 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology.
Contraindications
To date there are no known contraindications to the use of Sodium Iodide I 123 capsules.
Warnings and precautions
Females of childbearing age and children under 18 should not be studied unless the benefits anticipated from the performance of the test outweigh the possible risk of exposure to the amount of ionizing radiation associated with the test.
Adverse reactions
Although rare, reactions associated with the administration of Sodium Iodide isotopes for diagnostic use include, in decreasing order of frequency, nausea, vomiting, chest pain, tachycardia, itching skin, rash and hives.
Composition
- Active ingredients
- SODIUM IODIDE I-123 400uCi
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SODIUM IODIDE I-123 200uCi · CapsuleNDA018671-002 · Prescription
- SODIUM IODIDE I-123 400uCi · CapsuleThis page
- SODIUM IODIDE I-123 100uCi · CapsuleNDA018671-001 · Prescription
- SODIUM IODIDE I-123 200uCi · CapsuleANDA071910-001 · Prescription
- SODIUM IODIDE I-123 200uCi · CapsuleNDA017630-003 · Discontinued
At a glance
- Brand name
- Sodium Iodide I 123
- Active substance
- sodium iodide i-123
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Cardinal Health 418
- Status
- Discontinued
- FDA approval
- 27 May 1982
- Application
- NDA018671-003